lobbying_activities: 2116531
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2116531 | 1809a348-8fdf-41ba-9abd-ff00943b8611 | Q1 | 340B HEALTH | 316434 | 340B HEALTH | 2018 | first_quarter | PHA | The 340B Drug Pricing Program, FY18 LHHS Appropriations, FY19 LHHS Appropriations, final 2018 Outpatient Prospective Payment System Rule, proposed and final rules regarding 340B ceiling price calculations and manufacturer civil monetary penalties, S.2312, S.2453, H.R.4710, H.R.4392 | Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE | 269487 | 0 | 0 | 2018-04-19T14:54:56.703000-04:00 |